Jivi

Overview

Marketed

Generic name: Antihemophilic Factor (Recombinant), PEGylated-aucl
Product class: Recombinant FVIII (extended half-life, PEGylated)
Conditions: Hemophilia A
Route: IV

Important safety information

Use official prescribing information and your care team for treatment decisions. This directory gives no dosing advice or medication prices.

Official product information Report a side effect to FDA

Side-effect reports go directly to the FDA, the manufacturer and your HTC. HemoLife Social never receives or stores them. In an emergency, call your local emergency number.

Member experiences

Reviews and community posts are visible only to signed-in members.

Related listings

Adynovate

Sources

Imported: 2026-10-26 · Individual verification pending

https://www.bleeding.org/healthcare-professionals/guidelines-on-care/products-licensed-in-the-us
https://bleedingdisordersnc.org/the-who-what-guide/
https://www.fda.gov/BiologicsBloodVaccines/ucm618920.htm